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Abstract
Background: Most Yersinia pestis strains are known to express a capsule-like antigen, fraction 1 (F1)
. F1 is encoded by the
caf1 gene located on the large 100-kb pFra plasmid, which is found in Y. pestis but not in closely related species such as
Yersinia enterocolytica and Yersinia pseudotuberculosis. In order to find antibodies specifically binding to Y. pestis we
screened a large single chain Fv antibody fragment (scFv) phage display library using purified F1 antigen as a selection
target. Different forms of the selected antibodies were used to establish assays for recombinant F1 antigen and Y. pestis
detection.
Methods: Phage antibody panning was performed against F1 in an automated fashion using the Kingfisher magnetic bead
system. Selected scFvs were screened for F1-binding specificity by one-step alkaline phosphatase enzyme linked
immunosorbant assay (ELISA), and assayed for binding to recombinant antigen and/or Y. pestis by flow cytometry and
whole-cell ELISA.
Results: Seven of the eight selected scFvs were shown to specifically bind both recombinant F1 and a panel of F1-positive
Yersinia cells. The majority of the soluble scFvs were found to be difficult to purify, unstable and prone to cross-reactivity
with F1-negative Yersinia strains, whereas phage displayed scFvs were found to be easy to purify/label and remarkably
stable. Furthermore direct fluorescent labeling of phage displaying scFv allowed for an easy one-step flow cytometry assay.
Slight cross-reactivity was observed when fixed cells were used in ELISA.
Conclusions: Our high throughput methods of selection and screening allowed for time and cost effective discovery of
seven scFvs specifically binding Y. pestis F1 antigen. We describe implementation of different methods for phage-based
immunoassay. Based on the success of these methods and the proven stability of phage, we indicate that the use of phage-
displayed, rather than phage-free proteins, might generally overcome the shortcomings of scFv antibodies.
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Introduction
Yersinia pestis is a gram-negative, non-spore-forming bacterium
belonging to the family Enterobacteriaceae that is known to have
evolved from the enteric pathogen Yersinia pseudotuberculosis
approximately 20,000 years ago [1]. Among the eleven true
Yersinia species three are pathogenic to humans; Yersinia pestis,
Yersinia pseudotuberculosis and Yersinia enterocolytica, while all others
are harmless [2]. Y. pestis is the causative agent of the plague; an
illness that manifests itself in bubonic, pneumonic or septicaemic
forms that has resulted in the death of an estimated 200 million
people throughout history [2]. Once aerosolized, the infectious
agent can be dispersed and transmitted via inhalation causing
pneumonic plague, the least common but most virulent form,
which has the potential to cause high rates of morbidity and
mortality in humans.
Currently, Y. pestis is listed as a National Institute of Allergy and
Infectious Disease, Biodefense Category A Priority pathogen
(http://www3.niaid.nih.gov/topics/BiodefenseRelated/Biodefense/
research/CatA.htm), and is viewed as a high-priority agent that
poses a risk to national security because it is relatively easy to
acquire from the environment, and can be effectively dried and
converted into an aerosol form. Therefore the development of
methods for Y. pestis detection is relevant to public health and
biosurveillance.
Specific detection of a microorganism is based on recognition of a
genotypical or phenotypical feature unique to that microorganism
for which nucleic acid-based or immunological detection technol-
ogies are adopted respectively. Immunological detection is inher-
ently more rapid and therefore whenever possible preferable to
nucleic acid-based detection since minimal sample preparation is
required. Generally the development of immunoassays uses
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procedure to generate mAbs is time consuming (2–3 months), labor
intensive and requires immunization. Furthermore, all procedures
to derive mAbs with specific recognition characteristics (e.g.
recognizes target A, but not closely related target B) are carried
out at the screening stage. Because of the limitations of the number
ofcloneswhichcanbegrownupthislimitsthenumberofmAbsthat
can be assessed and the specificities that can be obtained.
In recent years, antibody phage display has become a very
popular method to isolate specific antibodies, bypassing hybrid-
oma technology and even the need for immunization. In general,
libraries are made up of either single chain Fv (scFv) or Fab
fragments, and comprise billions of different clones, from which
specific binders can be isolated by recursive selection cycles. One
of the advantages of using phage antibody libraries is that several
antibody fragments, binding to different epitopes, are usually
selected, providing a greater likelihood that useful binders will be
obtained. Traditional screening methods involve ELISA, a time
and cost ineffective way to analyze a large number of clones for
binding specificity. We have recently reported a multiplex flow
cytometry screening method [3] which allows the analysis of
hundreds of clones for binding specificity by simultaneously
assaying interaction with the target antigen and a vast array of
negative controls. This method has led to the discovery of sets of
scFvs with exquisite binding specificity to the target antigen and
potentially binding multiple epitopes within the antigen. Using
such in vitro methods for antibody fragments discovery has been
extremely successful, however the use of scFv as reagents in
research, diagnosis or detection has been limited by handling
issues: low production levels, aggregation and poor stability in
long-term storage. Where it is worth the additional effort, this
problem has been overcome by the transformation of these
antibody fragments into full-length antibodies. Unfortunately, this
conversion is resource intensive and cannot be practically carried
out on all selected antibody fragments.
F1 antigen is a capsular protein unique to most Y. pestis
[4,5,6,7,8] and therefore a good target for immunological
detection of this microorganism. The advantage of using
recombinant F1 as a selection target rather than the entire
organism is the reduced likelihood of developing antibodies against
components of the cell surface that are not associated to
pathogenicity. In an attempt to find scFv specifically recognizing
F1 antigen we have panned a large phage display library against
recombinant F1. In this report we describe selection of a set of
seven different aF1 scFv together with their rapid screening and
assay for binding specificity by multiplex flow cytometry and one-
step ELISA. More importantly we describe phage-based assays in
which filamentous phage displaying our selected aF1 scFvs
prepared using a helper cell-based method previously described
[9] are successfully used as ‘‘large antibodies’’ instead of the
soluble scFvs. Phage-scFvs have a number of advantages over the
use of free scFvs, including stability, ease of purification and
labeling. Furthermore even our weakest aF1 scFv shows binding
specificity in a phage display format. Therefore we believe that the
use of phage-displayed scFv may be generally applicable to a vast
array of scFv, overcoming the typical shortcomings of these
antibody fragments and avoiding the need for subcloning.
Results
aF1 scFv Antibody Selection, Screening and
Identification
Phage display technology was used to select multiple scFv clones
that specifically bound to recombinant F1 antigen. Following
library screening, the DNA pool representing the selected scFv
population was recovered, and full-length scFv open reading
frames were cloned into the pEP-AP vector (Figure S1A). This
expresses scFvs as alkaline phosphatase (AP) fusions allowing
identification of F1 binders by one-step ELISAs using recombinant
F1. Out of 252 clones analyzed, 35% did not express, 27%
expressed but did not bind either F1 or the negative control
antigen chicken Lysozyme, 2% expressed and reacted with both
F1 and chicken Lysozyme. Overall, 36% specifically bound F1
antigen and did not cross react with chicken Lysozyme. DNA
sequence analysis identified 8 unique aF1 scFv clones following
alignment of full-length amino acid sequences (Figure 1).
Assay of aF1 scFv Binding to Recombinant F1 Antigen
Binding of the 8 selected aF1 scFv antibodies, to recombinant
F1 antigen, was confirmed by one-step ELISA as well as multiplex
flow cytometry (Figure 2). One-step ELISA demonstrated that all 8
aF1- scFvs bound recombinant F1 antigen, when expressed as AP
fusion proteins and did not cross-react with an irrelevant antigen
(chicken Lysozyme, Figure 2A). In addition, each aF1 scFv
antibody was sub-cloned into a pEP-APEcoil vector (Figure S1B),
expressed as AP-Ecoil tag fusion proteins and fluorescently labeled
with Kcoil-Alexa Fluor 488 (Kcoil488), through high affinity
dimerization with Ecoil peptide tag [10]. Labeled scFv conjugates
were directly analyzed by multiplex flow cytometry without
purification, adopting a previously described protocol [3]. Analysis
was carried out by capturing biotinylated F1 or an irrelevant
biotinylated antigen (Ubiquitin) onto 2 different colored luminex
bead sets bound to neutravidin. The crude fluorescently labeled
aF1-APEcoil fusion proteins were incubated with the microsphere
duplex and directly analyzed using a LSRII flow cytometer
(Becton Dickinson). Flow cytometry analysis confirmed that 7 of
the 8 aF1-APEcoil scFv antibodies bound recombinant F1 and did
not cross-react with Ubiquitin (Figure 2B). The overall profile of
antibody reactivity when assayed by ELISA or flow cytometry was
similar (Figure 2). Generally, aF1 scFv clones 1, 3, 4, 6 and 8 gave
the highest binding signals whereas scFv 2 and 7 gave the lowest;
scFv clone 5 was weakly positive when analyzed by ELISA and
negative by flow cytometry.
Preparation of multivalent phage-displayed antibodies
Phage antibody libraries are a source of antibody fragments
with exquisite binding specificities [3,11,12,13,14,15], however, as
scFvs, such antibody fragments can be difficult to use, especially if
their expression levels and stabilities are low. This proved to be the
case with the aF1 antibodies here described, thus limiting their use
as detection reagents. Therefore we investigated the possibility of
using phage-bound antibodies -i.e. filamentous phage-displayed
scFvs- tailoring the subsequent immunoassays to this antibody
format. We prepared multivalent phagemid particles displaying
either one of our eight aF1 scFvs (CT1 through 8) or anti
Lysozyme scFv (CTD1.3) using the helper plasmid system M13cp-
CT previously developed in our laboratory [9]. This system has
been shown to produce high titers of multivalent phagemid
particles. Rapid normalization of CT phage concentrations used in
any given experiment was achieved by SDS-PAGE band
densitometry based on the intensity of the major protein p8. This
way of assessing phage concentrations was preferred to the most
commonly used phage titration based on determination of colony
forming unit (cfu), in order to avoid artifacts due to multivalent
display, namely lower titers caused by reduced phage infectivity
[16]. Phage concentrations determined using densitometry versus
titration were, as expected, mostly higher (CT3, CT5, CT8, D1.3)
and ranged between 3610
+13 and 8610
+11 as shown in Table S1.
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Phage scFv as Detection ReagentsThe most convenient way to assay the reactivity of our scFv-phage
reagents was flow cytometry using fluorescently labeled phagemid
particles. We used two labeling methods: in the first bound phage
was stained with aM13 primary antibody and PE-conjugated
secondary antibody, while in the second phage was directly labeled
with fluorescein, prior to binding, using a previously described
protocol [17] that resulted in each phagemid particle being labeled
with about 50–500 fluorophores (Table S2).
Assay of aF1-phage scFv Binding to Recombinant F1
Reactivity of the aF1 phage-displayed scFv (CT1 through 8)
with recombinant F1 was carried out by multiplexed flow
cytometry using a microsphere triplex bound to biotin, biotiny-
lated Lysozyme or biotinylated F1, with the first two bead sets
acting as negative controls for assessing specificity of F1 binding
(Figure 3A). Upon incubation with phage, binding events were
reported by staining with aM13 (mouse primary antibody) and
PE-conjugated aMouse (secondary antibody). Flow cytometry
analysis confirmed that, with the exception of scFv 5, all aF1 scFv
antibodies bound recombinant F1 and did not cross-react with
Lysozyme (Figure 3B). As expected, the negative control
aLysozyme phage-displayed scFv D1.3 (CTD1.3) bound Lyso-
zyme and did not cross-react with F1. Furthermore, with the
exception of CT8, none of the scFv-phage interacted with biotin-
bound beads. Similar results were obtained with the direct phage
labeling method (data not shown), therefore, directly labeled CT1
through 8 were further evaluated as detection reagents for cell-
based assay.
Figure 1. Amino acid sequence alignment of the 8 different aF1 scFv. 36% of the 252 clones that were screened by ELISA specifically bound
recombinant F1 antigen. 62 of the 90 positive clones were successfully sequenced. Eight different aF1 scFv groups were identified following
alignment of the full-length amino acid sequences obtained by translating the DNA sequences. One clone per group was selected. Here presented
are the amino acid sequences of the selected clones. Letters indicated in the following combination of foreground/background: black/white, blue/
torquoise, black/green, red/yellow and green/white, correspond to amino acids that are non-similar, conservative, similar, identical or weakly similar
respectively. The consensus sequence corresponds to amino acids that are represented at least in 3 of the 8 sequences. The boxed portions of the
consensus correspond to the CDRs (Kabat definition). With the red, green, blue, orange, black and pink boxes defining CDRL1 through 3 and CDRH 1
through 3 respectively.
doi:10.1371/journal.pone.0027756.g001
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All our aF1 phage clones were tested for binding to fixed Y. pestis
cells by flow cytometry (Figure 4) using CTD1.3 as negative
control. Assays were performed using equivalent amounts of
labeled phage. Average FITC labeling was 90 molecules of dye per
phage particle. All CT phages were initially tested for reactivity
with F1 positive Y. pestis A1122, and F1 negative strains Y.
pseudotuberculosis 0104 and Y. enterocolytica (Figure 4A). Significant
increments above CTD1.3 background binding were detected for
all aF1 CT phages with the exception of CT5, which was
confirmed to be inactive in accordance with previous results
(Figures 2 and 3). CT8 was identified as the phage with the
strongest binding to F1 positive strain Y. pestis A1122 and the
highest increment in fluorescent signal, over the negative control
CTD1.3 phage. Therefore CT8 was subsequently tested against a
panel of five F1-positive Y. pestis strains along with 3 F1-negative
Yersinia strains including Y. pestis Nairobi (Figure 4B). Results show
that the interaction of labeled CT8 with F1-positive Y. pestis strains
was between 3 and 8-fold stronger than binding to the most highly
reactive negative cell line, Y. pestis Nairobi. Since the cell-based
Figure 2. Binding analysis of aF1 scFv to recombinant F1 antigen. A) ELISA analysis: The aF1 scFv proteins were expressed as alkaline
phosphatase (AP) fusion proteins, recovered from the periplasmic fraction, and tested by one-step ELISA for binding to either recombinant F1 or
chicken Lysozyme, without further purification. The binding profile of each aF1 scFv clone presented, was not normalized for expression. B) Bead-
based flow cytometry analysis: The aF1 scFv proteins were expressed as AP-Ecoil fusion proteins, recovered from the periplasmic fraction and directly
labeled with Kcoil-A488. The fluorescently labeled aF1 were tested for binding to recombinant biotinylated F1 and ubiquitin by multiplex bead-based
flow cytometry, without further purification. The binding profile of each aF1-APEcoil scFv clone presented was not normalized for expression. The
value associated to each bar is an average of three experiments with corresponding standard deviation.
doi:10.1371/journal.pone.0027756.g002
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eventual artifacts due to cell fixation by comparing the reactivity of
aF1 phage with fixed versus live Yersinia strains (Figure 5). To this
end, ELISA was the assay of choice, despite it’s impracticality,
since the involvement of live cells made it necessary to conduct the
test in a containment level 3 laboratory where flow cytometry
resources were not available. Phage was incubated with blocked
Yersinia cells immobilized on plastic using Y. pestis (YP) Nairobi, Y.
pseudotuberculosis 0104 (YPT 0104) and Y. enterocolytica (YE) as F1-
negative controls. Phage binding events were reported using
horseradish peroxidase-conjugated anti M13 antibody (aM13-
HRP). Background noise coming from either the buffers or the
cells adhering to the wells was evaluated by including wells with no
added phage (‘‘no phage’’ in Figure 5). Non-specific phage
interaction with Yersinia cells was evaluated using negative control
phage CTD1.3. The absorbance values corresponding to this
control and the ‘‘no phage’’ control were negligible. Once again,
specificity of interaction was determined by comparing binding of
CT1-8 to F1-positive versus F1-negative strains. All active aF1
phages bound more strongly to the F1-positive cell lines than to
the mostly highly cross-reacting F1-negative strain YPT 0104 with
a maximum of 12-fold for CT4 binding to live YP A1122 and a
minimum of 2.5-fold for CT1 binding to fixed YP Kim. Whether
using live or fixed cells, the trend of binding specificity was similar
Figure 3. Bead-based flow cytometry analysis: aF1 phage reactivity with recombinant F1 antigen. A) Schematic of analysis: a set of 3
distinct luminex beads was bound to biotinylated Lysozyme, biotinylated F1 or biotin respectively. Bound phage was stained with aM13 mouse IgG
and phycoerythrin (PE)-conjugated goat aMouse. Beads were separated based on their intrinsic fluorescence (APC-A, APC-cyt7), and the associated
PE stain was measured to assess specificity of binding to F1 antigen. B) Assay results: Eight different aF1 scFv were expressed in phage format (CT1
through 8). Phage preparations were normalized to a concentration of 5610
+12 cfu/mL and analyzed for specific binding. The value associated to
each bar is an average of three experiments with corresponding standard deviation.
doi:10.1371/journal.pone.0027756.g003
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PLoS ONE | www.plosone.org 5 December 2011 | Volume 6 | Issue 12 | e27756Figure 4. Cell-based flow cytometry analysis: Fluorescent aF1 phage reactivity with fixed Yersinia cells. A) Reactivity of all aF1 scFv
phage clones with 3 fixed Yersinia strains: F1-positive Y. pestis A1122 and F1-negative strains Y. enterocolytica 0107 and Y. pseudotubeculosis 0104
were incubated with either aLysozyme (CTD1.3) or aF1 scFv-displaying FITC-labeled phage (CT1 through 8). The fluorescence associated with each
cell type was measured using FACS Calibur and data were analyzed by CellQuest. B) Reactivity of aF1 CT8 and CTD1.3 with 8 fixed Yersinia strains. F1-
positive Y. pestis strains A1122, C092, India, India 15 and Kim, and F1-negative strains Y. pestis Nairobi, Y. enterocolytica 0107 and Y. pseudotuberculosis
0104 were incubated with FITC-labeled phage. The value associated to each bar is an average of three experiments with corresponding standard
deviation.
doi:10.1371/journal.pone.0027756.g004
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cross-reactivity with fixed F1-negative YP Nairobi and YPT 0104
but not with their live counterpart.
aF1-phage scFv stability test
In order to further evaluate the usefulness of the aF1-CT phage
as detection reagents, the stability of the phage preparations was
determined (Figure 6). Three different phage-displayed aF1 scFv
antibodies, including 1 negative (CT5) and 2 positive (CT4 and
CT5) clones, were tested by ELISA for binding to live YP A1122
cells over a period of 9 months, using different storage conditions.
Results show that the phage preparations can be stored for up to 9
months at 4uC, followed by 2 months at room temperature,
without significant loss of activity.
Discussion
The initial aim of this study was to identify scFv antibodies that
could be used for Y. pestis immunodetection using a recombinant
form of one of the most common and species-specific surface
antigens of this organism, F1 [8], as a selection target. scFvs were
selected from a previously described large scFv phage display
library [18] using recombinant F1 as the selection target. 252
clones from the third cycle of library panning were screened after
recloning the scFvs as alkaline phosphatase (AP)-fused proteins.
Eight distinct clones were identified, further analysis of which was
greatly facilitated by expressing the scFv-AP fusion proteins with
an additional Ecoil peptide tag without loss of reactivity (Figure 2).
In this way crude proteins could be fluorescently labeled using
Kcoil peptides labeled with Alexa Fluor 488, in a one-step binding
protocol, without any further purification. By taking advantage of
the highly specific, high affinity Kcoil-Ecoil interaction [19]
labeled scFvs can be easily analyzed by high-throughput multiplex
flow cytometry [3]. This allowed us to confirm binding to
recombinant F1 and lack of cross reactivity to the negative antigen
by multiplex flow cytometry (Figure 2B), with very similar binding
profiles to those we obtained by ELISA (Figure 2A). This confirms
that when analyzing affinity reagents, multiplex flow cytometry
can be used as a rapid, more convenient (high data quantity and
low antigen consumption) alternative assay to ELISA.
Although we were able to carry out screening on crude proteins,
unfortunately, further characterization and potential development
Figure 5. Whole-cell ELISA analysis: aF1 phage reactivity with live or fixed Yersinia cells. Each phage-displayed aF1 (CT1 through 8) or
aLysozyme (CTD1.3) scFv was incubated with blocked live (A) or fixed (B) F1-positive Yersinia pestis (YP) A1122, Kim, India and India 195 or F1-
negative YP Nairobi, Yersinia pseudotuberculosis 0104 (YPT 0104) and Yersinia enterocolytica 0107 (YE 0107). Phage-binding events were reported
using aM13-HRP antibody. Background noise coming from buffers, secondary antibody or the cells was evaluated by including wells with no added
phage (no phage). The value associated to each bar is an average of three experiments with corresponding standard deviation.
doi:10.1371/journal.pone.0027756.g005
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yields, insufficient purity and instability. While particularly
valuable antibodies have been converted to full length IgG [12],
this procedure is relatively labor intensive and not suitable for all
our selected scFvs. In order to overcome this hurdle we
investigated the possibility of using phage antibodies themselves
– i.e. filamentous phage displaying scFvs - as detection reagents.
This has been previously reported [17,20], but not widely adopted.
In part, perhaps, because of the relatively low display levels
achievable when using a phagemid system: it is estimated that only
1% of phagemid particles actually display, and these display only a
single antibody fragment [21]. While this could have been
overcome by recloning each of the scFvs into a phage display
vector, we recently described a multivalent display system that can
be used to display scFvs in a multivalent format from phagemid
vectors without the need for subcloning [9]. In particular, the
M13cp-CT helper plasmid, in which p3 is truncated, showed the
strongest ELISA signals when compared to standard phagemid
display, or display using helper plasmids in which p3 was either full
length or completely deleted [9]. We were able to successfully
assay multivalent phage displaying aF1 (CT1 through 8) and
aLysozyme scFvs (CTD1.3) for binding to their respective antigens
by multiplex flow cytometry using phage labeled with mouse
aM13 IgG and phycoerythrin (PE)-conjugated goat anti-mouse as
immunochemical reagents (Figure 3). This assay confirmed that
when converted to phage format, 7 of the 8 scFvs specifically
interacted with F1 (scFv 5 was inactive).
We further studied the binding of phage-displayed scFv to Y.
pestis by whole-cell ELISA (Figure 5) and by flow cytometry
(Figure 4). In the former assay we used live and fixed cells, which
revealed that the use of fixed Y. pestis may lead to artifacts.
Furthermore, the live cell-binding profile was consistent between
all 7 aF1 phage-antibodies tested, with Y. pestis A1122 binding the
most, and Y. pestis India 195 binding the least (Figure 5A),
suggesting that all the scFvs may target the same F1 epitope. In the
flow cytometry assay we used directly labeled fluorescent phage,
which allowed us to streamline the protocol and reduce it to only
two simple binding and washing steps. The phage labeling
procedure was straightforward and resulted in an average of 250
fluorophore molecules per phage particle (Table S2). This level of
labeling is much higher than levels desirable when phage-free
proteins are labeled directly. In part this is due to the deleterious
effects of excessive labeling on protein function, which is less of a
problem when phage are directly labeled, as most of the label is
attached to the major coat protein p8 [17] and therefore less likely
to interfere with the function of the displayed scFv. Figures 3, 4
and 5 show the versatility of phage-displayed scFvs as demon-
strated by their successful use in a wide variety of assays. In the
cell-binding experiments (Figures 4 and 5), phage clearly bound to
those Y. pestis strains known to express F1, and did not bind to the
F1-negative strains. In the experiments testing binding to
recombinant F1 the signal to noise ratios obtained using phage-
displayed scFv (Figure 3B) are slightly lower than those obtained
with phage-free proteins (Figure 2B). However the specificity of
binding is clear in both cases, furthermore a slight reduction in
sensitivity is a price well worth to pay since phage-displayed scFvs
are far easier to purify/label and more stable than their self-
standing counterpart.
To our great surprise, prolonged storage of phage antibodies at
room temperature and/or 4uC did not compromise activity
(Figure 6). While phage infecting ability under extreme conditions
is known to be very stable [22], it is interesting that the binding
activity of displayed proteins also appears to be intact after many
months of storage. This suggests that appropriately designed assays
using well-characterized phage antibodies could be very useful as
reagents in suboptimal conditions. The use of phage antibodies as
immunochemical reagents has been previously reported for
western blotting and immunohistochemistry [20,23]. The work
reported here augments the number of assays for which phage
antibodies can be used to include flow cytometry.
In conclusion we have selected and characterized a set of scFv
that specifically bind recombinant F1 antigen. We have also
Figure 6. aF1 CT phage are stable, and reactive, following prolonged storage. Phage-displayed aF1 scFv CT4, CT6 and CT5 (inactive
control) were treated with a preservative solution and tested for reactivity following different storage conditions; A) freshly prepared phage, B) 6
months at 4uC, C) 9 months at 4uC followed by 1 month at room temperature (RT) and D) 9 months at 4uC followed by 2 months at RT. Phage was
tested for activity at non-saturating concentrations by whole-cell ELISA using live Yersinia pestis A1122 cells. Each value is an average of 3 experiments
with corresponding standard deviation.
doi:10.1371/journal.pone.0027756.g006
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and reliable reagents in immunoassays designed to detect the
presence of live or fixed F1-positive Yersinia pestis. Furthermore,
based on our results, we feel confident to generally state that
phage-displayed proteins might be more user-friendly reagents
than self-standing proteins, due to ease of purification, efficiency
and convenience of labeling protocols and exceptional stability.
Materials and Methods
Selection of aF1 scFv Antibodies by Phage Display
Preparation of Biotinylated F1 Antigen. The recombinant
F1 antigen was provided by DSTL labs (Porton Down, Salisbury,
Wiltshire). Purified F1 protein was biotinylated using EZ-LinkH
NHS-LC-LC Biotin (Pierce, 21343) according to the manu-
facturer’s instructions. The level of biotinylation was quantified as
3–5 molecules of biotin per mole of protein, using the EZ
TM Biotin
Quantification Kit (Pierce, 28005).
Panning. The scFv phage libraryhasbeenpreviously described
[18]. The selection procedure was automated using the Kingfisher
magnetic bead system (Thermo Lab Systems) and allowed panning
to be carried out in-solution. Prior to selection, 1610
+12 colony
forming units (cfu) of scFv phage library were blocked using 2% BSA
PBS + 0.01% Tween 20 (PBS-LT), at room temperature (RT) for
1 hina final volumeof 134 mL.Inthe first selection round,1.8 mgo f
biotinylated F1 antigen was incubated with the blocked scFv library
at room temperature (RT) for 1 h, in a final volume of 190 mL.
Following incubation, the scFv phage-F1 complexes were captured
onto 2610
+7 streptavidin magnetic beads (Dynabeads, M-280,
Miltenyi Biotech, 112.05D) by incubation at RT for 15 min. The
bead complex was then washed 3 times in 190 mL of PBS-LT and 3
times with 190 mLo fP B S+ 0.1% Tween 20 (PBS-T). The final scFv
phage binding population was eluted via incubation at RT for 3 min
and 30 s using 180 mL of 0.1 M glycine pH 2.2, and neutralized to
pH 7.5 by the addition of 50 mL 1 M Tris-HCl (pH 8.8). The eluted
scFv phage population was recovered by infecting 100 mLi n t o1m L
of Escherichia coli DH5aF’ cells at OD600 = 0.5, by static incubation
at 37uC for 45 minutes. The phage-infected bacterial cells were
platedonto2XYTagarcontaining100 mg/mLcarbenicillinand3%
Glucose (2XYT/Carb/Glu) and incubated overnight (O/N) at
30uC. The phage-infected bacterial cells were recovered in 2 mL of
2XYT/Carb/Glu broth, 10 mL of the bacterial suspension was
inoculated into 10 mL of 2XYT/Carb/Glu broth and incubated
with shaking (260 rpm) at 37uCu n t i lt h eO D 600 was 0.5. The cells
were subsequently co-infected with 1.3610
+13 cfu of M13K07
helperphage(AmershamPharmacia)bystaticincubationfor30 min
at 37uC. Following infection, the cells were recovered by
centrifugation at 3000 rpm for 30 min and re-suspended in 10 mL
of 2XYT broth containing 100 mg/mL carbenicillin, 25 mg/mL
kanamycin and incubated O/N at 30uC with shaking (260 rpm).
The amplified scFv phage were recovered within the media
supernatant by centrifugation at 3000 rpm for 30 min. 171 mLo f
the supernatant was used directly in the subsequent selection round.
The amplified phage particles were precipitated from the remainder
of the media supernatant by two rounds of PEG/NaCl precipitation
and stored at 4uC. The stringency of the selection conditions was
increased through 3 subsequent rounds of panning. The biotinylated
F1 antigen concentration was decreased 10 fold (from 600 nM to
60 nM) from the first to second, and third round and wash times
were increased (1, 5 and 15 min) with each subsequent round.
Screening of Selected aF1 scFv Antibodies
Expression of scFv antibodies as Alkaline Phosphatase
Fusion Proteins. The DNA encoding the scFv antibodies,
produced in the aF1 third round selection output, was recovered
from 100 mL of the infected bacterial cells, using the QIAprep spin
miniprep kit (Qiagen, 27104). The DNA, encoding full-length scFv
antibodies, was recovered by digestion with NEB restriction
enzymes BssHII and NheI, purified using QIAquick gel extraction
kit (Qiagen, 28704) and ligated into BssHII and NheI digested pEP-
AP vector (Figure S1A). 1 mL of the ligation reaction was
transformed into 50 mL of BL21 Gold DE3 electrocompetent
bacterial cells (Stratagene, 230132) and plated on kanamycin
(50 mg/mL) agar. Approximately 250 scFv clones were picked
using QBot (Genetix) and inoculated into 1 mL of kanamycin
selective (50 mg/mL) auto-induction media [24] in a 96 deep well
plate (Thomson Instrument Co., 951652). Following inoculation,
the plate was incubated with shaking at 18uC for 36 h. The cells
were recovered by centrifugation at 3,000 rpm for 30 min; the
supernatant was discarded and 300 mL of Popculture (Invitrogen,
71092) was added to the pellet (0.2-fold final concentration) and
incubated at RT for 15 min with shaking (900 rpm). 1 mL of PBS
was added to each well and the plate was centrifuged at 4,000 rpm
for 30 min to pellet bacterial debris. The supernatant containing
the scFv protein was transferred into a fresh 96 well deep well plate
and stored at 4uC.
One-Step ELISA. The expressed aF1-AP scFv fusion proteins
were analyzed by one-step ELISA for binding to recombinant F1
antigen, or cross reactivity to chicken Lysozyme. The ELISA was
automated using the liquid handling Genesis 2000 workstation
(Tecan). 192 wells of a 384 Maxisorp plate (NUNC #464718)
were coated with 0.1 mg of F1 antigen and all remaining wells
were pre-coated with 0.1 mg of chicken Lysozyme (Sigma, L7651),
allowing duplicate analysis of 96 different scFv clones against both
antigens. The plate was incubated O/N at 4uC and the following
day, unbound antigen was removed, the plate washed twice with
PBS-LT and blocked with 100 mL of 1% w/v BSA (Sigma,
A7906), by incubation for 1 h at RT. The block buffer was
removed and the plate washed twice with PBS-LT. 50 mL of scFv
antibody periplasmic extract was added, in duplicate, to wells
containing either Lysozyme or F1 antigen and incubated at RT for
1 h. The plate was washed 3 times with PBS-T and 3 times with
PBS-LT. Binding events were detected following addition of 80 mL
of Alkaline Phosphatase (AP) substrate p-Nitrophenyl Phosphate
Disodium Salt (PNPP, Pierce, 37620). In a second Maxisorp 96
well plate, individual scFv expression levels were determined by
addition of 10 mL of scFv antibody periplasmic extract to 80 mLo f
AP substrate. Immediately following addition of AP substrate, the
absorbance at 405 nm was measured using the SPECTRA fluor
Plus spectrofluorometer. The time zero value was deducted from
subsequent absorbance values generated as the AP signal increased
over time.
Sequencing of aF1 scFv. 62 clones, identified as positively
binding to F1 antigen by ELISA, were sequenced (Ohio State
University Plant-Microbe Genomics Facility) using forward primer
T7 Promoter (59 TAATACGACTCACTATA 39) and reverse
primer APRev (59 CAGGTTTATCGCTAAGAGAAT 39). The
resulting DNA sequence was analyzed using Vector NTI Advance
10 ContigExpress (Invitrogen) and translated, and aligned, using
Vector NTI Advance 10 Alignx (Invitrogen) to identify different
scFv groups.
Generation and Multiplex Flow Cyometry Analysis of
scFv-APEcoil. The DNA encoding 8 different scFv antibodies
was sub-cloned from the pEP-AP vector into pEP-AP-Ecoil vector
(Figure S1B) by digestion with NEB restriction enzymes BssHII
and NheI as described previously. Clones were sequenced with
both T7 Promoter (59 TAATACGACTCACTATA 39) and
APRev (59 CAGGTTTATCGCTAAGAGAAT 39). The eight
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(Stratagene, 230132), as described earlier, and analyzed by
multiplex flow cytometry as reported in [3]. Two different color-
coded, carboxylated microsphere suspension (LuminexH,
xMAP
TM 136 and 142), were coupled with neutravidin and
coated with either biotinylated F1 (bead set 136) or biotinylated
Ubiquitin (bead set 142). The antigen-coupled microspheres were
combined to create a duplex that was incubated with crude aF1
scFv labeled with Alexa Fluor 488-labelled Kcoil [19] (KcoilA488)
and directly analyzed by flow cytometry. The mean fluorescence
data of each bead set, within the multiplex, was collected using the
high-throughput analysis feature of the Becton Dickinson LSRII
flow cytometer and analyzed by DIVA software. The bead duplex
was separated into gates by excitation using a 633 nm laser and
emission detection through 780/60BP and 660/20BP filters. The
mean fluorescent value of each gate was recorded following
excitation using the 488 nm laser and emission detection through
a 530/80BP filter. 125 mL each sample was injected at a rate of
0.5 mL per sec and the mean fluorescence of 3000 gated,
microspheres was recorded.
Production and Labeling of Phage-displayed aF1 scFv
scFv Cloning in Phagemid Vector. BssHII and NheI
digested DNA fragments encoding each aF1 scFv antibody
(described earlier) were ligated into BssHII and NheI digested
pDAN5 [18]. Ligase mixtures were transformed into chemically
competent E. coli DH5aF’. Transformants were plated on 2XYT/
Carb/Glu agar. Two colonies were picked for each aF1 scFv,
inoculated onto 2XYT/Carb/Glu broth and incubated O/N at
37uC. The DNA from each clone was recovered using the
QIAprep spin miniprep kit (Qiagen) according to the
manufacturer’s instructions. Plasmids were used as template for
amplification of scFv genes with primers PDPH39 (59 TAA-
CGTCTGGAAAGACGACAA 39) and PDPH59 (59GCAG-
CCGCTGGATTGTTATTA 39). A PCR master mix was
prepared containing 395 mL Milli-Q autoclaved water, 50 mL
Taq thermo buffer (NEB), 20 mL dNTP (NEB, 10 mM each),
10 mLo f1 0 mM PDPH39 primer, 10 mLo f1 0 mM PDPH59
primer and 5 mL (25 units) of Taq Polymerase (NEB). 19.6 mL
master mix was mixed with 0.4 mL plasmid miniprep and
amplification occurred under the following conditions: 94uC for
5 min, (95uC for 45 sec, 55uC for 45 sec, 72uC for 1 min) 640
cycles, 72uC for 7 min. The identity of the clones was confirmed
by size, DNA fingerprinting (digestion with BstNI restriction
enzyme [25]) and sequencing.
Phage production. DNA plasmids, encoding each selected
aF1 and aLysozyme (negative control) scFv were transformed
into M13cp-CT helper cells [9]. The resulting single clone
transformants were used to produce phage (CT1 through 8 and
CTD1.3) according to the following protocol. O/N cultures of the
M13cp-CT helper cell transformants were obtained in 2 mL
2XYT supplemented with carbenicillin and chloroamphenicol (50
and 20 mg/mL respectively, 2XYT/Carb/Cap). 100 mL of O/N
culture was inoculated into 10 mL of 2XYT/Carb/Cap broth and
incubated at 37uCt oO D 600 = 0.5. Cells were centrifuged at
4,000 rpm for 15 min and cell pellets were re-suspended in 50 mL
2XYT supplemented with carbenicillin (25 mg/mL final
concentration, 2XYT-Carb). Following O/N incubation at 30uC
with shaking (260 rpm) the cultures were centrifuged at 4,000 rpm
for 30 min. The supernatant containing phage was recovered and
the phage was PEG/NaCl precipitated at 4uC O/N. Phage
precipitates were recovered by centrifugation at 10,000 rpm for
30 min. The resulting phage pellet was re-suspended in 15 mL
PBS and the suspension was cleared by centrifugation at
7,000 rpm for 15 min. The phage sample was PEG/NaCl
precipitated on ice for 1 h. Precipitated phage was recovered
following centrifugation at 10,000 rpm for 30 min, phage pellets
were resuspended in 1 mL PBS, cleared by centrifugation and
stored at 4uC. Phage was amplified from the phage stocks
according to the following method. M13cp-CT helper cells
overnight cultures were diluted 1:50 into 10 mL of 2XYT-Cap
broth and incubated at 37uCt oO D 600 = 0.5. Each phage stock
was diluted in 2XYT medium to a final concentration of
1.8610
+9 cfu/mL. 1.8E+9 cfu of each phage was added to
10 mL of M13cp-CT cell (1:1 multiplicity of infection). Infection
occurred at 37uC for 30 min, cells were harvested by cen-
trifugation and resuspended in 50 mL 2XYT-Carb. Additional
steps are as for previously described phage production protocol.
Phage concentration was determined by either titration (infection
of DH5aF’ with serial dilution of phage and plating onto LB-Carb
agar) or densitometry. For the latter method 10-fold diluted phage
solutions were analyzed by SDS-PAGE together with serial
dilution of wild type phage (M13K07) of known titer. The p8
band intensity of scFv-phage was translated into concentrations
using the equation defining the standard curve obtained by
plotting known M13K07 concentrations (determined by titration)
versus corresponding p8 band intensities.
Phage Labeling. CT1-8, CTD1.3 and wt phage was labeled
according to a slight modification of a previously described
procedure [17]. Phage preparations were PEG/NaCl precipitated
and re-suspended in bicarbonate buffer pH 9 (1 M, conjugation
buffer,). Fluorescein isothiocyanate (FITC, Sigma, F3651) was
added to a final concentration of 0.2 mg/mL from a 5 mg/mL
stock solution in conjugation buffer. Mixtures were incubated at
RT with rotation in the dark. Labeled phage were purified by three
cycles of PEG/NaCl precipitation and re-suspended in PBS. The
FITC concentration in each phage preparation was determined by
UV/vis absorbance (Abs494/71000) using unlabelled phage as
blank. The degree of labeling was determined by dividing FITC
concentration by phage concentration (both expressed as particles/
volume), resulting in a level of labeling ranging between 30 and 150
fluorophore molecules per phagemid particle.
Assay of Phage-displayed aF1 scFv
Multiplex Flow Cyometry Assay of Binding to
Recombinant F1. The multiplex flow cytometry assay was
performed according to a slight modification of a previously
described method [3]. Three different color-coded, carboxylated
microsphere (LuminexH, xMAP
TM), were coupled with neu-
travidin and coated with either biotinylated F1, biotinylated
Lysozyme (for assessment of binding specificity) or with biotin (no
antigen, for assessment of bead-binding level). Equal volumes of
the antigen-coupled microsphere suspensions were combined to
create a triplex (8 mL), that was incubated with 100 uL phage
(4610
+12 phage/mL determined by the densitometry-based
method described above) at RT for 1 h with mixing. Upon
washing the beads were re-suspend in 100 ml of 10-fold diluted
wonderblock (WB, PBS + 0.3% BSA, 0.3% fish gelatin, 0.3% milk,
WB) in PBS and 1:500 diluted mouse aM13 (ARP, 03-65197)
following incubation at RT for 1 h with shaking. After washing,
phage-bound beads were re-suspended in 100 ml of 10-fold diluted
WB in PBS and 1:1000 diluted goat anti-mouse-PE (Molecular
Probes, P21129). After more washing the beads were re-suspended
in 200 ml of PBS and analyzed by flow cytometry as described
above.
Yersinia Cell Preparation. All Y. pestis strains are described
in [26], and were originally obtained from the Reference
Collection of the Centers for Disease Control and Prevention,
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are F1-positive strains while Y. pestis Nairobi, Y. enterocolytica 0107
and Y. pseudotuberculosis 0104 are F1-negative strains. 1 ml of cell
glycerol stock was inoculated into 5 ml TSB (tryptone soya broth)
medium in a 50 mL falcon tube. The culture was incubated at the
28uC with moderate shaking (240 rpm) for 15–16 hours. Live cells
were directly re-suspended in PBS and used in the experimental
assay. Whereas those cells to be fixed were washed 3 times with
PBS and re-suspended in 4% paraformaldehyde. Cell death was
confirmed by culturing paraformaldehyde treated cells on TSB
agar plates for 2 days at 37uC.
Flow Cytometry Assay of Binding to Yersinia
Cells. Fixed cells were blocked by re-suspension in WB to a
final OD600 of 0.1 and incubated either at 4uC O/N or at RT for
1 h. Cells were harvested by centrifugation (10 min, 4000 rpm)
and re-suspended in a volume of PBS 10-fold lower than the
volume of blocking solution. 1 mL of blocked cells (about 1610
+6
cells) were incubated with 8 mL of FITC-labeled CT1-8
(6610
+11 cfu/mL) or 8 mL negative control phage (wt or
CTD1.3 4610
+12 cfu/mL) in 5-fold diluted WB. Cells were
incubated at RT for 2.5 h, washed twice with PBS and analyzed
by flow cytometry. The fluorescence intensity of each cell type was
measured on a FACSCalibur (Becton Dickinson, Franklin Lakes,
NJ) flow cytometer with laser excitation at 488 nm and
fluorescence emission collection through a 530/30 nm filter.
Untreated cells were also analyzed to assess auto fluorescence,
which was negligible. Resultant data were analyzed by CellQuest
software.
ELISA of binding to Yersinia cells. The ELISA was
performed in triplicate under Containment Level 3 Biosafety
conditions. 100 mL live or fixed Yersinia cells (in PBS OD600 = 0.2)
were transferred into each well of 96-well flat bottom Nunc
Maxisorp plate (Thermo Scientific, 449824). The plate was
incubated O/N at 4uC. Unattached cells were aspirated and
plate was washed once with PBS + 0.05% Tween 20 (wash buffer).
All the washes were performed by aspiration to eliminate the
creation of aerosols. The plate was blocked by addition of 250 ml
WB for 1 h at 37uC. scFv-phage (CT1-8 or CTD1.3 as a negative
control) was diluted to 4.5610
+9 cfu/mL (determined by
densitometry) in WB. 60 mL of each phage solution was added
to each well and the plate was incubated at RT with gentle
agitation for 2 h and then washed four times with wash buffer and
additional four times with PBS + 0.005% Tween 20. aM13-HRP
antibody conjugate (GE Healthcare, 27-9421-01) was diluted
1:1000 into 10-fold diluted WB and 60 mL was added to each well
of the plate. Following incubation at RT for 1 h, with shaking, the
plate was washed as described previously. 100 mL of TMB
substrate (Pierce, 34028) was added to each well and the
reaction was stopped by the addition of 50 mL1MH 2SO4. The
absorbance was read at 450 nm using victor3 plate reader
(PerkinElmer).
Phage Stability Test. CT4 CT6 and CT5 (negative control)
were solubilized in WB, protease inhibitor cocktail (Roche,
05892791001) and NaN3 (0.02% final concentration). Phage
clones were stored in various conditions including 4uC for 6
months; 4uC for 9 months followed by room temperature for 1
month; 4uC for 9 months followed by room temperature for 2
months. These phage samples and their freshly prepared
counterpart were tested by phage ELISA using live Y. pestis
A1122 as described above, in triplicate, using a fixed
concentration of phage (4.5610
+9 cfu/mL).
Supporting Information
Figure S1 Genetic maps of pEP-AP (A) and pEP-APEcoil
(B) vectors.
(TIFF)
Table S1 A typical set of phage concentrations: Con-
centration of phage displaying aF1 (CT1-8) or aLyso-
zyme (CTD1.3) scFv were obtained by standard titration
and by densitometry. Each value corresponds to the average of
two experiments.
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Table S2 A typical set of phage labeling efficiencies:
Upon labeling, concentration of phage displaying aF1 or
aLysozyme scFv (CT1-8 and CTD1.3 respectively) were
determined by densitometry and concentration of FITC
was determined by absorbance at 494 nm. Ratio of FITC
to phage concentration allowed determination of labeling
efficiency. Each value corresponds to the average of two
experiments.
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